XBiotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $867 | $0 | $0 |
Gross Profit | -439 | -442 | -439 | |
EBITDA | -1,289 | -10,325 | -9,906 | -4,364 |
EBIT | -1,728 | -10,767 | -10,345 | -4,803 |
Net Income | -1,756 | -10,884 | -10,508 | -5,015 |
Net Change In Cash | 0 | 867 | 0 | 0 |
Free Cash Flow | -6,040 | -6,814 | -6,624 | -6,183 |
Cash | 152,938 | 155,897 | 172,677 | 183,118 |
Basic Shares | 30,487 | 30,487 | 30,460 | 30,472 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $300 | $4,010 | $18,394 |
Gross Profit | -1,744 | 3,359 | 12,574 | |
EBITDA | -36,011 | -35,766 | -31,876 | -22,434 |
EBIT | -37,756 | -37,510 | -34,490 | -25,082 |
Net Income | -38,531 | -24,557 | -32,900 | -17,414 |
Net Change In Cash | 0 | 300 | 4,010 | 18,394 |
Cost of Revenue | -78,716 | -1,088 | ||
Free Cash Flow | -32,267 | -19,087 | -15,409 | 65,920 |
Cash | 172,677 | 200,023 | 157,306 | 236,983 |
Basic Shares | 30,460 | 30,438 | 30,439 | 30,043 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.06 |
2025-03-31 | -$0.35 |
2024-12-31 | -$0.34 |
